Maculaser

Developer of laser therapy for the treatment of retinal diseases

placeEspoo, Uusimaa, Finland calendar_todayFounded 2018 groups5 employees language maculaser.com

Innovation

4 patent families (4 granted) — focus: Human necessities; filing pace slowing. Cited 67 times.

YearFilings
20224
20233
20242
20252
20261

Social engagement

Social engagement: 1.6K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Innovestor.

Investor typeCountShare
Venture capital120%
Accelerator & incubator240%
Other / undisclosed240%
Coming soon